• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ GBS; NUCLEIC ACID AMPLIFICATION ASSAY SYSTEM, GROUP B STREPTOCOCCUS, DIRECT SPECIMEN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ GBS; NUCLEIC ACID AMPLIFICATION ASSAY SYSTEM, GROUP B STREPTOCOCCUS, DIRECT SPECIMEN Back to Search Results
Catalog Number 441772
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/13/2024
Event Type  malfunction  
Manufacturer Narrative
D2.Additional medical device type: ooi.H3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that while testing with the bd max¿ gbs, a false positive result was obtained.A confirmatory culture was performed and resulted as negative.There was no report of patient impact.Report 1 of 3.
 
Event Description
It was reported that while testing with the bd max¿ gbs, a false positive result was obtained.A confirmatory culture was performed and resulted as negative.There was no report of patient impact.Report 1 of 3.
 
Manufacturer Narrative
Investigation summary the complaint investigation for discrepant results when using the bd max gbs kit (ref.441772) lot 3291548 was performed by the review of manufacturing records, review of customer¿s data and by the complaint¿s history review.Customer complained about discrepancies between gbs target results obtained with bd max¿ gbs kit lots 3291548 and culture for one patient.Review of manufacturing records of the bd max gbs indicated that the lot 3291548 was manufactured according to specifications and met performance requirements.Customer provided the scanned first page of run reports (b)(4) and (b)(4) from instrument (b)(4), and culture results report from an external laboratory for investigation.Customer¿s notation on the reports allowed to identify the affected samples as samples a7 (run (b)(4) and b5 (run (b)(4).Analysis of the runs revealed that both these samples were from the same patient and gave positive results.Run (b)(4) was performed on b)(6) 2024 and run (b)(4) on (b)(6) 2024.Since sample b5 (run (b)(4) sbt was tested outside of bd¿s recommended stability window (4h), it is considered invalid and should have been repeated with a new sbt.Analysis of the culture report revealed that the patient obtained a positive result with the strep b carrot broth¿ test, which was sent to another laboratory for culture testing and then gave a culture negative result for gbs.Limit of detection can vary between different method of detection.Despite multiple attempts made to receive information from the customer, no data was provided for the investigation.Without data, bd is unable to identify the cause of the customer issue.The root cause was not identified.However, specimen at or near the assay limit of detection (lod) of the laboratory culture method could explain the customer¿s discrepant results.There is no indication of a reagent issue based on the analysis of the complaints received for discrepant results on bd max gbs lot 3291548.Bd cannot confirm the complaint based on the investigation that was performed.Bd did not initiate a corrective and a preventive action plan since no new hazard or trends was identified.Bd apologizes for the inconvenience that this may have caused.Bd quality will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAX¿ GBS
Type of Device
NUCLEIC ACID AMPLIFICATION ASSAY SYSTEM, GROUP B STREPTOCOCCUS, DIRECT SPECIMEN
Manufacturer (Section D)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer (Section G)
BECTON DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jo doyka
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key19013475
MDR Text Key339129481
Report Number3007420875-2024-00028
Device Sequence Number1
Product Code NJR
UDI-Device Identifier00382904417727
UDI-Public(01)00382904417727
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K111860
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number441772
Device Lot Number3291548
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/07/2024
Initial Date FDA Received04/01/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/18/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-